About Matinas BioPharma Hlds (MTNB). Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering. Stock analysis for Matinas BioPharma Holdings Inc (MTNB:NYSEAmerican) including stock price, stock chart, company news, key statistics, fundamentals and. The current price of MTNB is USD — it has decreased by −% in the past 24 hours. Watch Matinas Biopharma Holdings, Inc. stock price performance more. A clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology. A high-level overview of Matinas BioPharma Holdings, Inc. (MTNB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The. The stock symbol for Matinas BioPharma is "MTNB." What Is the Matinas BioPharma Market Cap? As of today, Matinas BioPharma market cap is. MTNB | Complete Matinas BioPharma Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Low commission rates start at $0 for U.S. listed stocks & ETFs*. Margin loan rates from % to %. Open An Account. Stock Data ; Alliance Global Partners, Scott Henry, | [email protected] ; Maxim Group, Jason McCarthy, | [email protected] Matinas Biopharma Holdings Inc. ; Sep 6 Sep 11 ; 4 ; 0 60k. Discover real-time Matinas Biopharma Holdings, Inc. Common Stock (MTNB) stock prices, quotes, historical data, news, and Insights for informed trading and. See the latest Matinas BioPharma Holdings Inc stock price (MTNB:XASE), related news, valuation, dividends and more to help you make your investing. On Thursday morning 09/05/ the Matinas BioPharma Holdings Inc Registered Shs share started trading at the price of $ Compared to the closing price on. Matinas BioPharma Holdings, Inc. Stock Data Charting. Matinas Biopharma Holdings Inc. NYSE American: MTNB. Events Earnings Dividends Splits Price Price %. Matinas BioPharma Holdings Inc. · AT CLOSE PM EDT 09/04/24 · USD · % · Volume,
On Tuesday morning 08/27/ the Matinas BioPharma Holdings Inc share started trading at the price of $ Compared to the closing price on Monday 08/26/ Find the latest Matinas BioPharma Holdings, Inc. (MTNB) stock quote, history, news and other vital information to help you with your stock trading and. The average one-year price target for Matinas BioPharma Holdings, Inc. is $ The forecasts range from a low of $ to a high of $ On Tuesday, Matinas BioPharma Holdings Inc (MTNB:ASQ) closed at , % above its week low of , set on Sep 06, week range. Today. Sep MTNB Matinas Biopharma Holdings Inc. 11, $ $ (%). Today. Watchers, 11, Wk Low, $ Wk High, $ Market Cap, $M. The average one-year price target for Matinas BioPharma Holdings, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price. Key Stats · Market CapM · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change For the upcoming trading day on Monday, 9th we expect Matinas Biopharma Holdings Inc to open at $, and during the day (based on 14 day Average True Range). Matinas Biopharma Holdings Inc. ; , , , ; , --, --,
Matinas BioPharma Holdings Inc ; Previous Close: ; Open: ; Volume: 12, ; 3 Month Average Trading Volume: ; Shares Out (Mil): Matinas BioPharma Holdings, Inc. ; MTNB. NYSE American ; $ Stock Price ; Change ; k. Volume. Matinas Biopharma Holdings Inc is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker MTNB. Matinas BioPharma (MTNB) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies.
Matinas BioPharma
About Matinas Biopharma (MTNB) · Open. $ · High. $ · Low. $ · 52 Week High. $ · Monthly Return. % · Revenue. $ Based on 1 Wall Street analysts offering 12 month price targets for Matinas BioPharma in the last 3 months. The average price target is $ with a high. MTNB Stock Performance ; Previous close, ; Day range, - ; Year range, 0 - 0 ; Market cap, 35,, ; Primary exchange, NYSE MKT. Market. Shares outstanding. M Market cap. $M Enterprise value. $M Valuations. Price to earnings (P/E). N/A. Price to book (P/B) · Per share. EPS. Matinas BioPharma Holdings Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A.
Miracle Gro Stock Price | How To Change Car Insurance Policy